QuantiFERON-TB Gold (T.Spot) at Lahore PCR Lab

QuantiFERON-TB Gold (T.Spot) at Lahore PCR Lab

The QuantiFERON-TB Gold (QFT) and T-SPOT.TB tests are advanced, evidence-based laboratory investigations classified as Interferon-Gamma Release Assays (IGRAs). These molecular and immunological diagnostic tools are utilized at Lahore PCR Lab in Lahore, Pakistan, to detect infection caused by the bacterium Mycobacterium tuberculosis. Unlike traditional diagnostic methods, these blood-based assays measure the body’s cell-mediated immune response to specific tuberculosis antigens. This modern diagnostic approach provides clinicians with highly specific and sensitive data, assisting in the crucial differentiation between latent tuberculosis infection (LTBI) and active tuberculosis disease when combined with clinical findings.

The technology behind these assays relies on the stimulation of T-lymphocytes in whole blood. When a patient has been infected with Mycobacterium tuberculosis, their memory T-cells recognize specific mycobacterial proteins—specifically Early Secretory Antigenic Target-6 (ESAT-6) and Culture Filtrate Protein-10 (CFP-10). In the laboratory setting, the patient’s blood sample is exposed to these synthetic peptide antigens. If the patient has prior exposure to tuberculosis, their sensitized T-cells release a cytokine known as interferon-gamma (IFN-γ). The QuantiFERON-TB Gold assay quantifies this interferon-gamma concentration using an Enzyme-Linked Immunosorbent Assay (ELISA), while the T-SPOT.TB assay utilizes an Enzyme-Linked Immunospot (ELISPOT) technique to count individual interferon-gamma-secreting T-cells. Both methodologies represent the pinnacle of modern immunodiagnostics, offering significant advantages over historical testing methods.

The primary clinical value of IGRAs performed at Lahore PCR Lab lies in their exceptional specificity. Traditional screening, such as the Tuberculin Skin Test (TST) or Mantoux test, is highly susceptible to false-positive results in individuals who have received the Bacillus Calmette-Guérin (BCG) vaccine—a common scenario in Pakistan. Because the ESAT-6 and CFP-10 antigens are entirely absent from the BCG vaccine strain and most non-tuberculous mycobacteria, the QuantiFERON-TB Gold and T-SPOT assays do not cross-react with BCG vaccination. This makes them the diagnostic gold standard for tuberculosis screening in vaccinated populations, ensuring accurate detection without unnecessary medical intervention.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your QuantiFERON-TB Gold or T-SPOT.TB test at Lahore PCR Lab, patients should adhere to the following preparation guidelines:

• No Fasting Required: Patients do not need to fast before this blood test. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform the laboratory staff and your prescribing physician of all medications you are currently taking, particularly corticosteroids, immunosuppressants, or chemotherapy agents, as these can suppress T-cell function and lead to indeterminate results.
• Timing of Other Tests: If you have recently received a live-virus vaccine (such as MMR or yellow fever), it is recommended to either perform the IGRA test on the same day or wait at least four to six weeks, as live vaccines can temporarily suppress cell-mediated immunity.
• Hydration: Drink plenty of water before the procedure to facilitate easier venous access for the phlebotomist.

During the Procedure

The collection process for tuberculosis interferon-gamma release assays is highly specialized and requires meticulous laboratory technique:

• Patient Positioning: You will be seated comfortably in a phlebotomy chair. The phlebotomist will locate a suitable vein, typically in the antecubital fossa of your arm.
• Aseptic Technique: The skin over the selected vein will be thoroughly sanitized with an antiseptic solution to prevent contamination.
• Specimen Collection: For the QuantiFERON-TB Gold test, a unique set of four specialized, color-coded tubes (Nil, TB1, TB2, and Mitogen) is used. Each tube must be filled to an exact volume (typically 1 mL per tube) to ensure the correct ratio of blood to antigen. For the T-SPOT.TB test, a standard lithium heparin or sodium heparin tube is collected.
• Immediate Processing: The specialized QuantiFERON tubes must be shaken gently immediately after collection to ensure the blood mixes thoroughly with the antigens coated on the tube walls. They are then transported to the incubator within a strict timeframe.
• Duration and Experience: The entire venipuncture procedure takes less than five minutes. You may feel a brief pinch as the needle is inserted, but the process is virtually painless.
• Safety Considerations: All collections at Lahore PCR Lab utilize sterile, single-use, disposable vacuum tube systems to eliminate any risk of cross-contamination or infection.

When is a QuantiFERON-TB Gold (T.Spot) Performed?

1. Screening Prior to Biologic or Immunosuppressive Therapy

Physicians routinely request a QuantiFERON-TB Gold or T-SPOT test before initiating patients on advanced biologic therapies, particularly tumor necrosis factor-alpha (TNF-α) inhibitors, or long-term systemic corticosteroids. These medications suppress the immune system, which can cause a dormant, latent tuberculosis infection to reactivate into life-threatening active pulmonary or extrapulmonary tuberculosis. Performing this screening allows clinicians to detect and treat latent tuberculosis prophylactically before starting immunosuppressive regimens.

2. Contact Tracing After Active Tuberculosis Exposure

When an individual is diagnosed with active, infectious pulmonary tuberculosis, public health protocols require thorough contact tracing. Family members, close friends, and co-workers who have shared indoor air space with the infectious individual are at high risk of contracting the infection. Lahore PCR Lab performs IGRA testing on these contacts to determine if transmission has occurred, allowing for early intervention and preventing the further spread of the disease within the community.

3. Healthcare Worker and Occupational Screening

Healthcare professionals, laboratory technicians, and individuals working in correctional facilities or long-term care homes in Lahore face an elevated risk of occupational exposure to tuberculosis. Routine surveillance using QuantiFERON-TB Gold or T-SPOT testing is a critical component of infection control programs. This regular monitoring ensures that any occupational acquisition of the bacterium is identified promptly, protecting both the healthcare workforce and the vulnerable patients they serve.

4. Evaluation of Patients with Symptoms of Active TB

While IGRAs cannot distinguish between latent and active tuberculosis on their own, they serve as a valuable diagnostic adjunct when patients present with clinical symptoms suggestive of active disease. These symptoms include a persistent cough lasting more than three weeks, hemoptysis (coughing up blood), unexplained weight loss, drenching night sweats, low-grade chronic fever, and persistent fatigue. A positive result confirms exposure and immunological recognition, prompting further diagnostic steps such as sputum acid-fast bacilli (AFB) staining, culture, and chest imaging.

5. Screening Immunocompromised Individuals

Patients living with human immunodeficiency virus (HIV), those undergoing organ transplantation, or individuals suffering from end-stage renal disease requiring hemodialysis have severely compromised cell-mediated immunity. These populations are exceptionally vulnerable to severe, disseminated forms of tuberculosis. Regular screening with highly sensitive assays like the T-SPOT.TB, which is particularly robust in immunocompromised cohorts due to its standardized cell-counting methodology, is vital for managing patient safety and survival.

What Does a QuantiFERON-TB Gold (T.Spot) Detect?

The QuantiFERON-TB Gold and T-SPOT assays are designed to detect specific immunological markers and clinical scenarios, including:

• Latent Tuberculosis Infection (LTBI): Detection of viable, dormant Mycobacterium tuberculosis bacilli residing within granulomas in the body without causing active clinical symptoms.
• Active Pulmonary Tuberculosis: Immunological confirmation of exposure in patients presenting with active lung parenchymal disease.
• Extrapulmonary Tuberculosis: Assistance in diagnosing TB infections localized outside the lungs, such as in the lymph nodes, pleural cavity, abdomen, genitourinary tract, central nervous system, or bones.
• Sensitization to ESAT-6 Antigen: Specific T-cell response to the Early Secretory Antigenic Target-6, indicating exposure to pathogenic mycobacteria.
• Sensitization to CFP-10 Antigen: Specific T-cell response to the Culture Filtrate Protein-10, confirming immunological memory of tuberculosis.
• CD4+ T-Cell Response: Evaluation of helper T-lymphocyte activation and interferon-gamma release upon antigen stimulation.
• CD8+ T-Cell Response: Assessment of cytotoxic T-lymphocyte activation (specifically measured in newer QuantiFERON-TB Gold Plus assays) to provide a more comprehensive picture of the immune response.
• Anergy or Immunosuppression: Detection of a lack of immune responsiveness through the Mitogen (positive control) tube, indicating that the patient’s immune system is unable to mount a response.
• High Background Interferon-Gamma: Identification of elevated baseline immune activity through the Nil (negative control) tube, which may occur due to heterophile antibodies or non-specific immune activation.
• Differentiation from BCG Vaccine Strain: Confirmation that a positive screening result is due to actual tuberculosis infection rather than prior BCG vaccination.
• Differentiation from Most Non-Tuberculous Mycobacteria (NTM): Exclusion of environmental mycobacterial exposure, as the test antigens are absent in almost all NTMs (except M. kansasii, M. szulgai, and M. marinum).
• Recent Transmission: Detection of newly acquired infection in contact investigation scenarios.
• Baseline Immunological Status: Establishing a pre-treatment baseline before starting anti-TNF-alpha or other biologic therapies.
• Occupational Acquisition: Monitoring seroconversion in high-risk occupational environments.
• Pediatric TB Exposure: Assisting in the diagnosis of tuberculosis infection in children, where sputum collection is often challenging.
• Miliary Tuberculosis Adjunct: Supporting the diagnosis of disseminated, life-threatening miliary tuberculosis.
• Tuberculous Meningitis Adjunct: Providing rapid immunological support in suspected cases of central nervous system tuberculosis.
• Tuberculous Pleural Effusion: Assisting in identifying the etiology of unexplained pleural fluid accumulation.
• Renal Tuberculosis Support: Helping identify the cause of sterile pyuria or chronic kidney symptoms related to mycobacterial infection.
• Gastrointestinal TB Support: Aiding in the differentiation between Crohn’s disease and intestinal tuberculosis in complex clinical presentations.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are critical for patient management and peace of mind. The QuantiFERON-TB Gold and T-SPOT.TB assays involve complex incubation and ELISA/ELISPOT processing steps. Typically, the final verified report is available within 48 to 72 hours from the time of sample collection. This turnaround time ensures that the samples undergo rigorous quality control, incubation, and analysis by our expert laboratory scientists.

Patients and referring physicians can easily access reports online through the secure portal of Lahore PCR Lab. Once the results are finalized and verified by our consultant pathologist, an automated SMS notification is sent to the patient’s registered mobile number containing a direct link to download the electronic report. Physical copies of the reports can also be collected directly from our main diagnostic facility in Lahore, Pakistan.

QuantiFERON-TB Gold Findings Overview

The following table outlines the parameters evaluated during the QuantiFERON-TB Gold and T-SPOT.TB assays, along with their clinical interpretations:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Nil Control (Negative Control)	Low level of interferon-gamma (≤ 8.0 IU/mL)	Elevated baseline interferon-gamma (> 8.0 IU/mL), rendering the test indeterminate due to non-specific immune activation.
TB Antigen minus Nil (TB1/TB2)	Low interferon-gamma response (< 0.35 IU/mL)	Elevated interferon-gamma response (≥ 0.35 IU/mL and ≥ 25% of Nil), indicating immunological recognition of M. tuberculosis.
Mitogen Control (Positive Control)	High interferon-gamma response (≥ 0.50 IU/mL)	Low interferon-gamma response (< 0.50 IU/mL) when TB antigen is negative, indicating T-cell anergy or severe immunosuppression (Indeterminate result).
ESAT-6 Response (T-SPOT)	0 to 4 spot-forming cells (SFCs)	≥ 8 spot-forming cells (SFCs), indicating a positive immunological reaction to the ESAT-6 antigen.
CFP-10 Response (T-SPOT)	0 to 4 spot-forming cells (SFCs)	≥ 8 spot-forming cells (SFCs), indicating a positive immunological reaction to the CFP-10 antigen.
Overall Interpretation	Negative (No evidence of M. tuberculosis infection)	Positive (Infection with M. tuberculosis detected) or Indeterminate (Uninterpretable due to low mitogen or high nil).
Immune Status Assessment	Fully functional cell-mediated immunity	Impaired cell-mediated immunity, leading to potential false-negatives or indeterminate results in highly immunocompromised patients.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for QuantiFERON-TB Gold (T.Spot)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, molecular biologists, and skilled phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict internal and external quality control protocols to ensure maximum accuracy and reproducibility of all test results.
• Professional Reporting: Our reports are detailed, clear, and structured to provide clinicians with the precise quantitative data they need for clinical decision-making.
• Modern Diagnostic Approach: We utilize state-of-the-art ELISA and molecular diagnostic equipment to perform complex immunological assays.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience for patients of all ages.
• Convenient Location: Located centrally in Lahore, Pakistan, our facility is easily accessible for patients from all parts of the city.
• Commitment to Accurate Diagnosis: We understand the critical nature of tuberculosis screening and are committed to delivering reliable results that guide effective clinical management.